ZAPHYR PHARMACEUTICALS IRELAND LIMITED

Zaphyr Pharmaceuticals Ireland Limited acts as a strategic gateway to the pharmaceutical market of the Middle East and Africa (MEA). The company focuses on in-licensing, out-licensing and commercialising high-quality FDA and European-approved innovative medicines and branded generics, primarily targeting chronic disease therapies. By expanding its portfolio and manufacturing capabilities into the MEA region, Zaphyr aims to deliver life-changing, cost-effective treatments to patients across a rapidly growing market.

Beyond product supply, Zaphyr offers a comprehensive suite of partner-focused services designed to accelerate business growth in the region. These include consultancy, business development and tailored support that help collaborators navigate regulatory landscapes, establish market presence and optimise commercial strategies. With a clear emphasis on innovation and partnership, Zaphyr Pharmaceuticals Ireland Limited positions itself as a reliable ally for companies seeking to enter or expand within the dynamic MEA pharmaceutical arena.